Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs

We assessed the performance of REMA in comparison with BACTEC MGIT 960 in the susceptibility testing of 80 Mycobacterium tuberculosis clinical isolates from Clemente Ferreira Institute against four drugs. REMA proved to be a rapid and accurate method, providing excellent correlation with BACTEC MGIT...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata, Marcelo, Pavan, Fernando Rogério, Sato, Daisy Nakamura, Marino, Leonardo Biancolino, Hirata, Mario Hiroyuki, Cardoso, Rosilene Fressati, de Melo, Fernando Augusto Fiúza, Leite, Clarice Queico Fujimura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brazilian Society of Microbiology 2013
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804211/
https://www.ncbi.nlm.nih.gov/pubmed/24159317
http://dx.doi.org/10.1590/S1517-83822013005000028
_version_ 1782288121870680064
author Miyata, Marcelo
Pavan, Fernando Rogério
Sato, Daisy Nakamura
Marino, Leonardo Biancolino
Hirata, Mario Hiroyuki
Cardoso, Rosilene Fressati
de Melo, Fernando Augusto Fiúza
Leite, Clarice Queico Fujimura
author_facet Miyata, Marcelo
Pavan, Fernando Rogério
Sato, Daisy Nakamura
Marino, Leonardo Biancolino
Hirata, Mario Hiroyuki
Cardoso, Rosilene Fressati
de Melo, Fernando Augusto Fiúza
Leite, Clarice Queico Fujimura
author_sort Miyata, Marcelo
collection PubMed
description We assessed the performance of REMA in comparison with BACTEC MGIT 960 in the susceptibility testing of 80 Mycobacterium tuberculosis clinical isolates from Clemente Ferreira Institute against four drugs. REMA proved to be a rapid and accurate method, providing excellent correlation with BACTEC MGIT 960, with the exception of results for the ethambutol drug.
format Online
Article
Text
id pubmed-3804211
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Brazilian Society of Microbiology
record_format MEDLINE/PubMed
spelling pubmed-38042112013-10-24 Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs Miyata, Marcelo Pavan, Fernando Rogério Sato, Daisy Nakamura Marino, Leonardo Biancolino Hirata, Mario Hiroyuki Cardoso, Rosilene Fressati de Melo, Fernando Augusto Fiúza Leite, Clarice Queico Fujimura Braz J Microbiol Short Communication We assessed the performance of REMA in comparison with BACTEC MGIT 960 in the susceptibility testing of 80 Mycobacterium tuberculosis clinical isolates from Clemente Ferreira Institute against four drugs. REMA proved to be a rapid and accurate method, providing excellent correlation with BACTEC MGIT 960, with the exception of results for the ethambutol drug. Brazilian Society of Microbiology 2013-05-14 /pmc/articles/PMC3804211/ /pubmed/24159317 http://dx.doi.org/10.1590/S1517-83822013005000028 Text en Copyright © 2013, Sociedade Brasileira de Microbiologia All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License CC BY-NC.
spellingShingle Short Communication
Miyata, Marcelo
Pavan, Fernando Rogério
Sato, Daisy Nakamura
Marino, Leonardo Biancolino
Hirata, Mario Hiroyuki
Cardoso, Rosilene Fressati
de Melo, Fernando Augusto Fiúza
Leite, Clarice Queico Fujimura
Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs
title Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs
title_full Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs
title_fullStr Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs
title_full_unstemmed Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs
title_short Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs
title_sort comparison of resazurin microtiter assay performance and bactec mgit 960 in the susceptibility testing of brazilian clinical isolates of mycobacterium tuberculosis to four first-line drugs
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804211/
https://www.ncbi.nlm.nih.gov/pubmed/24159317
http://dx.doi.org/10.1590/S1517-83822013005000028
work_keys_str_mv AT miyatamarcelo comparisonofresazurinmicrotiterassayperformanceandbactecmgit960inthesusceptibilitytestingofbrazilianclinicalisolatesofmycobacteriumtuberculosistofourfirstlinedrugs
AT pavanfernandorogerio comparisonofresazurinmicrotiterassayperformanceandbactecmgit960inthesusceptibilitytestingofbrazilianclinicalisolatesofmycobacteriumtuberculosistofourfirstlinedrugs
AT satodaisynakamura comparisonofresazurinmicrotiterassayperformanceandbactecmgit960inthesusceptibilitytestingofbrazilianclinicalisolatesofmycobacteriumtuberculosistofourfirstlinedrugs
AT marinoleonardobiancolino comparisonofresazurinmicrotiterassayperformanceandbactecmgit960inthesusceptibilitytestingofbrazilianclinicalisolatesofmycobacteriumtuberculosistofourfirstlinedrugs
AT hiratamariohiroyuki comparisonofresazurinmicrotiterassayperformanceandbactecmgit960inthesusceptibilitytestingofbrazilianclinicalisolatesofmycobacteriumtuberculosistofourfirstlinedrugs
AT cardosorosilenefressati comparisonofresazurinmicrotiterassayperformanceandbactecmgit960inthesusceptibilitytestingofbrazilianclinicalisolatesofmycobacteriumtuberculosistofourfirstlinedrugs
AT demelofernandoaugustofiuza comparisonofresazurinmicrotiterassayperformanceandbactecmgit960inthesusceptibilitytestingofbrazilianclinicalisolatesofmycobacteriumtuberculosistofourfirstlinedrugs
AT leiteclaricequeicofujimura comparisonofresazurinmicrotiterassayperformanceandbactecmgit960inthesusceptibilitytestingofbrazilianclinicalisolatesofmycobacteriumtuberculosistofourfirstlinedrugs

Ejemplares similares